Do we really have an urgency for a fourth dose of ...
The latest COVID-19 outbreak in China has raised the debate for the urgency for a fourth dose! The question is do we really need a fourth dosage
The latest COVID-19 outbreak in China has raised the debate for the urgency for a fourth dose! The question is do we really need a fourth dosage
The US Food and Drug Administration (US FDA) approved the first generic version of AbbVie Inc.’s dry-eye drug Restasis.
A clot in a blood vessel in the brain can cause an ischemic stroke. Ischemic stroke remains one of the leading causes of death despite advanced treatment options such as thrombolytic therapy which dissolves blood clots and intravascular catheter treatment which mechanically removes a clot.
COVID-19 can affect the upper respiratory tract (sinuses, nose, and throat) and the lower respiratory tract (windpipe and lungs). | The Executive Headlines
Shares of COVID-19 vaccine producers fell after US President Joe Biden endorsed a proposed waiver for intellectual property rights, despite the pharmaceutical sector, analysts, and experts dismissing its significance. | The Executive Headlines
Elevate your understanding of the world of business with Best Business Magazine and news platform. The Executive Headlines genuinely support all top business leaders and the innovative technological ecosystem that surrounds and engages with them. The company ' logo encapsulates our entire idea; it comprises a magazine for influential business leaders and decision-makers. Offering up-to-the-minute, all-encompassing news coverage, market perspectives, and exclusive dialogues with corporate pioneers, we are your ultimate destination for remaining at the vanguard of the business sphere. Enroll with us today and position yourself at the forefront of business acumen with Best News Platform and Business Magazine